July 8, 2011


Elanco buys Janssen Pharmaceutica


Elanco, a division of Eli Lilly and Company, has completed the acquisition of animal health firm, Janssen Pharmaceutica NV, which belongs to the Janssen Pharmaceutical Companies umbrella.


Janssen Animal Health has operations in 11 countries and focuses on targeted disease segments in companion animals and livestock with special focus on pigs and poultry.


According to terms of the transaction, Elanco will acquire products, contracts and related intellectual property and marketing authorisations. Affected employees, located in 11 different countries, will transfer to Elanco to support a significantly expanded portfolio of products.

Video >

Follow Us